The overall tone suggests cautious support, with comments like 'This study confirms what we've seen in practice,' indicating agreement. Interest appears moderate, driven by statements such as 'Good to see evidence supporting safety,' and engagement remains fairly superficial, with many users simply noting the study's reassuring results rather than critically engaging with its methodology. The perceived impact is recognized but not heavily emphasized, reflecting a common attitude of cautious acceptance of the research findings.
AgreementModerate agreement
Most discussions acknowledge that the study provides reassurance about the safety of olmesartan and similar medications.
InterestModerate interest
Participants show moderate curiosity, often discussing the implications for clinical practice or medication choices.
EngagementNeutral engagement
While some include detailed references to the study's methodology, many reactions are surface-level reflections without deep analysis.
ImpactModerate impact
The discussions suggest the findings could influence prescribing habits but lack extensive advocacy or urgency.
Abstract in brief
The study investigated whether olmesartan, an angiotensin receptor blocker, increased the risk of sudden cardiac death or overall death compared to other similar medications, based on data from 2002 to 2009.
Researchers found that users of olmesartan had similar risks for cardiac death and all-cause mortality as those taking other ARBs or ACE inhibitors, with no significant increase in danger.
Overall, the study concluded that olmesartan does not seem to pose a higher risk of serious heart-related deaths compared to other blood pressure medications in the analyzed population.
Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors https://t.co/vUwSzZZ1M3 https://t.co/atYTzfpZIb
This video provides a detailed analysis of a study investigating cardiac mortality risks associated with olmesartan, other ARBs, and ACE inhibitors. The study concludes that olmesartan does not pose a higher risk of…
This video presents a detailed analysis of a study examining whether olmesartan increases the risk of cardiac or overall mortality compared to other ARBs and ACE inhibitors. The research finds similar risks across these…
Cardiac mortality in users of olmesartan, other angiotensin-receptor blockers and angiotensin-converting enzyme inhibitors https://t.co/vUwSzZZ1M3 https://t.co/atYTzfpZIb
Biomass and Biofuels From Microalgae (Navid) | PDF | Algae Fuel ...
News
... pds gene expression via the RNA interference approach in Dunaliella salina ... 10.1002/adfm.201300104. Krames MR, Ochiai-Holcomb M, Hofler GE, Carter ...
Faizal Bux, Yusuf Chisti Eds. Algae Biotechnology Products and ...
News
doi:10.1002/anie.201200218. Mirn, A. S., Garca, M. C. C, Gmez, A. C., et al ... (PDS) gene was observed to be involved in carotenoid biosynthesis. These ...
Latin-American Seeds - Agronomic, Processing and Health Aspects ...
News
doi.org/10.1002/fsn3.2071. Nájera, S. 2015. ¿Tiene la producción de ... Agriculture and Food Chemistry 63: 3551−3558. Gepts, P., and D. Dpbouk. 1991 ...
HCI International 2022 - Late Breaking Papers: Design, User ...
News
3558–3565. Association for Computing Machinery, New York, NY, USA (2016) 6 ... 10.1002/dac.4590 52. Schaupp, L.C., Festa, M.: Cryptocurrency adoption ...
Bioprospecting - Success, Potential and Constraints | PDF | Mass ...
News
archaea and bacteria extend over geographical distances and cross the domain barrier. MicrobiologyOpen 2(5):811–825. doi:10.1002/mbo3.115 ... Delabona PDS, Pirota ...
Silk Road Book Main Document | PDF | Silk Road | Pakistan
News
https://doi.org/10.1002/pa.1954. Khan, A. A., Baig, S. M., & Muhammad, F ... https://orcid.org/0000-0001-9095-3558. Department of Management Studies ...
2021 Gastrointestinal Surgical Emergencies | PDF | Emergency ...
News
... PDS) should be performed promptly to the concerns of the potential for ... 10.1002/ibd.21275 disease of the ileum. Dis Colon Rectum. Published online ...
... 10.1002/2014WR015338. Hunter, J. (2007), Estimating sea-level extremes in a ... (PDS) approach was adopted to estimate probabilities for events occurring ...
doi:10.1002/2015GL064088. [40] Herrick, R. R.; Phillips, R. J. (1993) ... Radar Measurements. Science 139 (3558): [132] Greeley, Ronald; Batson, Raymond M.
Food Governance in European Systems | PDF | Consumption ...
News
DI 10.1002/jsfa.8128. UT WOS:000403232500029. PM 27804134. ER. PT J AU Abebe, GK ... Public Distribution System (CORE-PDS) SO JOURNAL OF PUBLIC AFFAIRS SN ...
Therapeutic Applications of Dopamine D3 Receptor Function ...
News
... 10.1002/ajmg.b.30731. Hughes JR, Keely J, Naud S (2004) Shape of the relapse ... 3558. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y et ...
ESICM/ESCMID Task Force On Practical Management of Invasive ...
News
... P3558.html. ... Pharmacoepidemiol Drug Saf 16:919–927. 83. Sinnollareddy MG, Roberts JA, Lipman J et al (2015) Pharmacokinetic https://doi.org/10.1002/pds.1365
Exploring The Top 50 Drugs Associate Source Nat Sci Sleep So ...
News
doi:10.1002/pds.677 20. Bate A, Lindquist M, Edwards IR, et al. A Bayesian ... doi:10.5665/sleep.3558 53. Kamal RM, Van Noorden S, Ernst F, Dijkstra BA ...
Antihypertension and Risk of Dementia | PDF | Dementia ...
News
... 3558 (1.2) 33 421 (7.5) Concurrent or previous use of drugs (90 days ... https://doi.org/10.1002/pds. general practices in Germany. J Alzheimers Dis ...
nocodelowcode3 | PDF | Artificial Intelligence | Intelligence (AI ...
News
doi: 10.1002/9781119636113.ch42. [44] D. Wang, X. Ma, and A. Y. Wang, 'Human ... 3558–3565. doi: 10.1145/2851581.2856492. [51] G. Dove, K. Halskov, J ...
Biomedical Applications of Biodegradable Polymers | PDF | Tissue ...
News
been commercialized as the monofilament suture PDS® for nearly 30 years.337 In an effort ... 2004; 25:3553–3558. [PubMed: 15020129] 595. Pang Z, Lu W, Gao ...